Hikal Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Press release on the financial results of the Company for the quarter and half-year ended September 30, 2025".
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hikal Limited has shared a press release with the stock exchange covering its financial results for the quarter and half-year ended September 30, 2025. The announcement itself is a formal intimation about the press release rather than the detailed results. Hikal is a chemical and pharmaceutical company, so the results will reflect performance across its CDMO and crop protection segments. Investors should refer to the attached press release or the company's Q2 results filing for specific revenue, profit, and margin figures. The detailed numbers, segment-wise performance, and management commentary are not included in this intimation.
This is a routine disclosure — the actual numbers in the press release will determine whether the stock reacts positively or negatively. Shareholders should review the detailed results to assess revenue growth, profitability, and any management guidance for the rest of the fiscal year.